New York’s attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.
New York’s attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.